Get the Stockscreener App
53.01
0.65%
0.34
Pre-market:
52.70
-0.31
-0.58%
Bruker Corp stock is traded at $53.01, with a volume of 1.85M.
It is up +0.65% in the last 24 hours and up +10.37% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$52.67
Open:
$52.17
24h Volume:
1.85M
Relative Volume:
0.72
Market Cap:
$8.05B
Revenue:
$3.44B
Net Income/Loss:
$75.20M
P/E Ratio:
101.18
EPS:
0.5239
Net Cash Flow:
$49.30M
1W Performance:
+12.52%
1M Performance:
+10.37%
6M Performance:
+28.45%
1Y Performance:
-13.45%
1-Day Range:
$51.95
$53.27
1-Week Range:
$46.85
$53.47
52-Week Range:
$28.53
$64.64
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
53.01 | 8.00B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
127.04 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.77 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.83 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker acquires remaining 60% stake in TOFWERK for full ownership By Investing.com - Investing.com Canada
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets - Financial Times
How to listen in as Bruker joins J.P. Morgan's big health event - Stock Titan
Is Bruker (BRKR) Pricing Reflecting Its Life Sciences Role And Mixed Valuation Signals? - Yahoo Finance
Bruker Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Bruker (BRKR) Is Up 7.9% After Winning €35 Million ELI-NP Order In Romania - simplywall.st
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $53 - 富途牛牛
Why Bruker (BRKR) Stock Is Up Today - Finviz
AbCellera settles patent litigation with Bruker over microfluidic device tech - MSN
Bruker (BRKR) Receives Analyst Rating and Price Target Upgrade f - GuruFocus
Winners And Losers Of Q3: Bruker (NASDAQ:BRKR) Vs The Rest Of The Research Tools & Consumables Stocks - Finviz
Benchtop X-Ray Diffraction Platform | Bruker AXS GmbH | Jul 2023 - Photonics Spectra
Insider Stock Buying Reaches US$1.14m On Bruker - 富途牛牛
Bruker secures $10M in federally funded NMR orders from NYSBC, Delaware, and Northwestern - MSN
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) Competitors - Meyka
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide - AOL.com
Should You Continue to Hold BRKR Stock in Your Portfolio? - Finviz
Bruker (BRKR) Is Up 6.8% After Settling AbCellera Dispute And Securing Major ELI-NP Contracts - Yahoo Finance
Does Bruker’s 2025 Share Price Slide Present a Hidden Opportunity? - Yahoo Finance
3D Measuring Device | Bruker Alicona | May 2024 - Photonics Spectra
Bruker (BRKR) Valuation Check After €35m ELI-NP Contract Win Drives Fresh Growth Hopes - Yahoo Finance
Bruker Corporation $BRKR Shares Sold by Orion Porfolio Solutions LLC - MarketBeat
Bruker (MIL:1BRKR) EV-to-OCF : 73.37 (As of Dec. 20, 2025) - GuruFocus
Will AbCellera’s (ABCL) Bruker Patent Settlement and Royalties Shift Its Long-Term Revenue Narrative? - simplywall.st
Why Bruker Corporation stock appeals to dividend seekersMarket Trend Review & Weekly Watchlist for Consistent Profits - DonanımHaber
Will Bruker’s (BRKR) AbCellera Settlement and Beacon Royalties Deal Change Its Investment Narrative? - simplywall.st
Will Bruker Corporation stock continue upward momentumMarket Growth Summary & Real-Time Stock Movement Alerts - Улправда
Why Bruker Corporation stock is rated strong buy2025 Buyback Activity & Long-Term Safe Investment Plans - ulpravda.ru
Can Bruker Corporation stock maintain growth trajectoryWeekly Investment Report & Long Hold Capital Preservation Tips - ulpravda.ru
AbCellera stock jumps after settlement with Bruker in patent dispute - Investing.com
Bruker (BRKR) Agrees to $36M Settlement with AbCellera (ABCL) - GuruFocus
AbCellera settles patent dispute with Bruker for $36 million upfront - Investing.com
AbCellera and Bruker Reach Global Settlement of Patent Litigation - Yahoo Finance
Volume Summary: Will Bruker Corporation stock continue upward momentumProfit Target & High Return Stock Watch Alerts - ulpravda.ru
How Recent Analyst Shifts Are Reshaping The Bruker Investment Story - Yahoo Finance
YieldBoost Bruker From 0.4% To 11.2% Using Options - Nasdaq
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $55 to $60 - 富途牛牛
Bruker Corporation $BRKR Shares Sold by Squarepoint Ops LLC - MarketBeat
Reassessing Bruker’s 2025 Valuation After Share Price Rebound And Life Sciences Expansion - simplywall.st
Bruker Is Maintained at Overweight by Barclays - 富途牛牛
Wells Fargo Raises Bruker (BRKR) Price Target to $55 | BRKR Stoc - GuruFocus
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
Bank of America Raises Bruker (NASDAQ:BRKR) Price Target to $60.00 - MarketBeat
Bruker Is Maintained at Buy by B of A Securities - 富途牛牛
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $55 - 富途牛牛
BRKR: Analyst Maintains 'Buy' Rating and Raises Price Target to $60 | BRKR Stock News - GuruFocus
Bruker (BRKR): Reassessing Valuation After a Sharp Three-Month Share Price Rebound - simplywall.st
London Co. of Virginia Reduces Holdings in Bruker Corporation $BRKR - MarketBeat
Does Bruker (NASDAQ:BRKR) Have A Healthy Balance Sheet? - 富途牛牛
Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR) - Insider Monkey
Stocks making big moves this week: Monolithic Power Systems, Alphabet, Enova, Revolve, and Bruker - Yahoo Finance
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):